Hysterosalpingography for assessing efficacy of essure microinsert permanent birth control device

Michael H. Wittmer, Abimbola O. Famuyide, Douglas J. Creedon, Robert P. Hartman

Research output: Contribution to journalArticlepeer-review

20 Scopus citations


OBJECTIVE. The Essure microinsert is a new U.S. Food and Drug Administration-approved method of birth control. The objective of this study is to report our initial experience using hysterosalpingography (HSG) to assess its efficacy for permanent tubal occlusion. CONCLUSION. The Essure microinsert produced tubal blockage in all patients. As this device may become more widely used, radiologists should be aware of the device's appearance and be able to assess device position and presence of tubal occlusion on HSG.

Original languageEnglish (US)
Pages (from-to)955-958
Number of pages4
JournalAmerican Journal of Roentgenology
Issue number4
StatePublished - Oct 2006
Externally publishedYes


  • Birth control
  • Fallopian tube
  • Genitourinary tract imaging
  • Hysterosalpingography
  • Reproductive organ imaging

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging


Dive into the research topics of 'Hysterosalpingography for assessing efficacy of essure microinsert permanent birth control device'. Together they form a unique fingerprint.

Cite this